| Patents for C07K - Peptides (3,738) |
|---|
| 08/27/2009 | US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215049 Novel litaf binding site peptides and methods of using the same |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/19/2009 | EP2090319A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 08/18/2009 | US7576056 Peptides and compounds that bind to a receptor |
| 08/18/2009 | US7575751 Activin-A mutants |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/12/2009 | EP1616181B1 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101502648A 疫苗 Vaccine |
| 08/11/2009 | US7574340 Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| 08/11/2009 | US7572894 Preparing a fibrous protein smectic hydrogel by way of a solvent templating process |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/05/2009 | CN101498731A Human monoclonal antibody against a costimulatory signal transduction molecule ATLIM and pharmaceutical use thereof |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/29/2009 | CN100519751C Optimization of cell for endogenous gene activation |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP1597274B1 Hsp60 from arthrobacter |
| 07/22/2009 | CN101486761A Human coagulation factor VII variants |
| 07/22/2009 | CN101486756A Outer surface proteins, their genes, and their use |
| 07/21/2009 | US7563769 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/21/2009 | US7563448 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181034 Antibodies and related molecules that bind to psca proteins |
| 07/15/2009 | CN101481409A BASB027 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses |
| 07/09/2009 | US20090176964 Stabilized Alpha Helical Peptides and Uses Thereof |
| 07/08/2009 | EP1601683A4 Novel non-invasive marker for liver disease |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 06/23/2009 | US7550430 Bactericides; immobilized |
| 06/18/2009 | US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 06/18/2009 | US20090155819 Mammalian T1R3 Sweet Taste Receptors |
| 06/18/2009 | US20090155246 Antibodies Specific For Soluble Amyloid Beta Peptide Protofibrils and Uses Thereof |
| 06/16/2009 | US7547767 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149630 Stabilized Alpha Helical Peptides and Uses Thereof |
| 06/11/2009 | US20090149540 Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury |
| 06/10/2009 | EP2067483A1 Analogues of GLP-1 |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/09/2009 | US7544777 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/03/2009 | EP1620456A4 Hla-a2 tumor associated antigen peptides and compositions |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/14/2009 | US20090124538 Selective R-cadherin antagonists and methods |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | CN100486642C 疫苗 Vaccine |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/06/2009 | EP2055189A1 Glycopegylation methods and proteins/peptides produced by the methods |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/22/2009 | CN100480267C Corticotropin releasing factor 2 receptor agonists |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | CN101410530A Immuno-amplification |
| 04/09/2009 | WO2005047305A3 Cellular membrane protein assay |
| 04/09/2009 | WO2004113361A3 Novel prokineticin receptor isoforms and methods of use |
| 04/09/2009 | US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | CN100475959C Coagulation factor VII anamorphosis |
| 04/07/2009 | US7514529 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/02/2009 | WO2005019239A3 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity |
| 04/02/2009 | WO2004094456A3 Immuno-amplification |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/01/2009 | CN101397574A Flavivirus NS1 subunit vaccine |
| 04/01/2009 | CN101397335A Particles of HCV envelope proteins: use for vaccination |
| 03/26/2009 | WO2005014615A3 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/26/2009 | WO2004087733A3 Prevention and treatment of alzheimer amyloid deposition |
| 03/26/2009 | US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507788 Peptides and methods for cell death regulation |
| 03/19/2009 | US20090074864 Novel antimicrobial peptides with heparin binding activity |
| 03/18/2009 | CN101389654A Novel non-invasive marker for liver disease |
| 03/18/2009 | CN101385851A Methods and compositions for healing and repair of articular cartilage |
| 03/17/2009 | US7504097 Interferon-alpha polypeptides and conjugates |
| 03/12/2009 | US20090068235 Immunogenic cd19 peptides |
| 03/11/2009 | EP2033654A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/05/2009 | WO2005014618A3 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 03/05/2009 | US20090061502 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
| 02/26/2009 | US20090053742 Capture and release based isotope tagged peptides and methods for using the same |
| 02/25/2009 | CN101371923A BAFF receptor (BCMA), an immunoregulatory agent |
| 02/19/2009 | US20090047284 Methods and compositions for PDGF-C activation and inhibition |